Company intelligence / Profile preview

GenScript

Ownership: Public · 1548.HK
Employees: ~2000
Development stage: Commercial

Overview

GenScript has established itself as the world’s largest provider of gene synthesis services and a global leader in life science research tools. Its technologies underpin thousands of academic and industrial projects worldwide. The company supports early-phase drug discovery but does not directly report clinical trial results for proprietary therapeutics. It has enabled significant advances in synthetic biology and biotherapeutic R&D.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Gene synthesispeptidesproteinsantibodies (including monoclonal and rabbit mAbs)CRISPR/Cas genome editing reagentscell linesplasmidspreclinical drug development tools
Industry: Drug Discovery Services

Partnerships

NSG BioNumerous pharmaceutical companies (via CRO/CDMO services)

Beyond the preview

Go deeper on GenScript.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenScript.

Explore the full profile